Fresenius Medical Care AG (FMCQF) Stock Price & Analysis
Fresenius Medical Care AG (FMCQF) — price $44.53 (0.00%), as of the Nov 19, 2026 trading session; market cap $11.6B.
Educational signal · not a buy or sell recommendation · How to read this
Fresenius Medical Care AG · FMCQF
Fresenius Medical Care AG & Co. KGaA is a global leader in dialysis care and related services, operating an extensive network of outpatient clinics and manufacturing a wide array of dialysis products.
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $44.53 | |
| Change on the day | 0.00% | |
| Market capitalisation | $11.6B | — |
| Price / earnings (trailing) | 13.28 | |
| Shares traded on the day | 100 |
Price & events
Other perspectives
Council score for Fresenius Medical Care AG (FMCQF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 12, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 12, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 12, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Fresenius Medical Care AG (FMCQF), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Fresenius Medical Care AG (FMCQF) is the company analyzed here. It employs 106,291 people. In Q3 FY2026 it reported revenue of €4.94B and net income of €160M. The market values it at $11.6B.
What do the latest results show for Fresenius Medical Care AG (FMCQF)?
Short answer · as of
The most recent reported quarter, Q3 FY2026, carried revenue of €4.94B. Against analyst estimates the company has EPS beat 6 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2026 | €4.94B | €160M | €0.61 (diluted) |
| Q2 FY2026 | €4.85B | €218M | €0.81 (diluted) |
| Q1 FY2026 | €4.63B | €118M | €0.43 (diluted) |
| Q4 FY2025 | €5.07B | €327M | €1.14 (diluted) |
What are the financial strengths and risks for Fresenius Medical Care AG (FMCQF)?
Short answer · as of
The distress and quality screens read Altman Z 1.72 · Piotroski F 8. Trailing ratios: ROE 6.3% · ROA 2.6% · current ratio 0.99 · earnings yield 7.6% · free-cash-flow yield 16.5%.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held FMCQF in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported FMCQF in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Fresenius Medical Care AG Stock: Key Questions Answered
These answers are editorial: 2 of these 8 answers are drawn from the FMCQF research dossier (written Jun 15, 2026 by gemini-2.5-flash); the other 6 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is FMCQF a good stock to buy?
Stock Expert AI does not rate FMCQF buy, sell or hold. Fresenius Medical Care AG has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the FMCQF stock price today?
The last price recorded for Fresenius Medical Care AG (FMCQF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
How does Fresenius Medical Care AG & Co. KGaA manage reimbursement pressures in the healthcare sector?
Fresenius Medical Care AG & Co. KGaA operates in a healthcare sector highly susceptible to reimbursement pressures from government and private payers.
What are the main risks for FMCQF?
The main risks for Fresenius Medical Care AG & Co. KGaA include ongoing reimbursement pressures from government and private payers, which can directly impact revenue and profitability.
What are the key factors to evaluate for FMCQF?
Evaluate FMCQF on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. Growth in Home Dialysis Solutions and Support: The shift towards home-based care is a significant trend in healthcare, offering patients greater flexibility and potentially reducing healthcare costs. Not financial advice.
How frequently does FMCQF data refresh on this page?
FMCQF's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven FMCQF's recent stock price performance?
Fresenius Medical Care AG (FMCQF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider FMCQF overvalued or undervalued right now?
The trailing P/E of Fresenius Medical Care AG (FMCQF) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 13 figures on this page — 9 from Financial Modeling Prep (FMP) and 4 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com